migraine patients. Migraine without aura[commen migraine
Conditions
Interventions
Intervention 1: Control group: patients will be exposed to the inhalation of liquid paraffin produced by Kimiagar Toos Company. In experimental group a ball soaked with 2 drops of liquid paraffin will
Treatment - Drugs
Control group: patients will be exposed to the inhalation of liquid paraffin produced by Kimiagar Toos Company. In experimental group a ball soaked with 2 drops of liquid paraffin will be attached to
Experimental group will be exposed to the inhalation of lavender essence produced by Barij certified pharmaceutical company with quality standards of ISO 9001 and ISO/IEC 17025. Lavender essence is pr
Sponsors
Vice chancellor for research Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: being over 18 years; alertness and ability to communicate; at least 6 months of having migraine headache; don't have a cold; don't using perfume before and during the intervention; having good snse of smell according to the neurological examination; having criterias of migraine without aura according to the classification of International headache society (IHS); don't using psychiatric drugs specially anti-depressants drugs; Under prophylactic treatment by Depakin 500 produced by Sa nofi aventis one time every night, under treatment of acute phase of headache by NSAID at the incidence of headache . Exclusion criteria: pregnancy or decision to pregnancy; record of allergies; Acute respiratory disease; addiction; allergy during intervention.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression. Timepoint: Before intervention first week, two weeks after intervention and four weeks after intervention. Method of measurement: Beck Depression scale.;Headache disability. Timepoint: Before intervention first week, two weeks after intervention and four weeks after intervention. Method of measurement: Headache disability inventory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Allergic to lavender. Timepoint: During four weeks of intervention. Method of measurement: Questions from patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzar jafari Koulaee
Mazandaran University of Medical science
Outcome results
None listed